NASDAQ:AERI
Delisted
Aerie Pharmaceuticals Stock News
$15.25
+0 (+0%)
At Close: Feb 17, 2023
HC Wainwright & Co. Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $31
11:21am, Thursday, 07'th May 2020Aerie Pharmaceuticals (AERI) Reports Q1 Loss, Lags Revenue Estimates
09:15pm, Wednesday, 06'th May 2020
Aerie (AERI) delivered earnings and revenue surprises of -12.00% and -3.32%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Aerie Pharmaceuticals Q1 EPS $(0.840) Misses $(0.770) Estimate, Sales $20.341M Beat $20.060M Estimate
08:05pm, Wednesday, 06'th May 2020Aerie Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
08:01pm, Wednesday, 06'th May 2020
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients wi
Aerie Pharmaceuticals, Inc. to Host Earnings Call
07:00pm, Wednesday, 06'th May 2020
NEW YORK, NY / ACCESSWIRE / May 6, 2020 / Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) will be discussing their earnings results in their 2020 First Quarter Earnings call to be held on May 6, 2020 at 5:0
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
12:00am, Wednesday, 06'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs May 5)
• Adverum Biotechnologies...
Aerie Pharmaceuticals to Present at the Bank of America Securities 2020 Healthcare Conference
11:30am, Tuesday, 05'th May 2020
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients wi
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Aerie Pharmaceuticals Inc (NASDAQ:AERI) Sees Large Increase in Short Interest
08:50am, Saturday, 02'nd May 2020
Aerie Pharmaceuticals Inc (NASDAQ:AERI) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 9,720,000 shares, an increase of 5.
Analysts' Top Healthcare Picks: Lemaitre Vascular (LMAT), Aerie Pharma (AERI)
12:51pm, Friday, 01'st May 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Lemaitre Vascular (LMAT), Aerie Pharma (AERI) and BioLife
Analysts’ Top Healthcare Picks: Lemaitre Vascular (LMAT), Aerie Pharma (AERI)
12:51pm, Friday, 01'st May 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Lemaitre Vascular (
LMAT
–
Research Report
), Aerie Pharma (
AERI
–
Research Report
) and BioLife S
Global Ophthalmology Therapeutics Market (2020 to 2024) - Featuring AbbVie, Aerie Pharmaceuticals & Bayer Among Others
08:58am, Friday, 01'st May 2020
Dublin, May 01, 2020 -- The "Global Ophthalmology Therapeutics Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The author has.
Needham Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $38
12:39pm, Thursday, 30'th Apr 2020Aerie Pharmaceuticals Inc (NASDAQ:AERI) Shares Sold by Cwm LLC
10:57am, Thursday, 30'th Apr 2020
Cwm LLC trimmed its holdings in Aerie Pharmaceuticals Inc (NASDAQ:AERI) by 4.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission
Needham Thinks Aerie Pharma's Stock is Going to Recover
09:52am, Thursday, 30'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Aerie Pharma (AERI) today and set a price target of $38.00. The company's shares closed last
